FindTrial
Sign In

Clinical Study to evaluate the Efficacy and Safety of EASY CLIMB CAPSULES in Patients with Painful knee Osteoarthritisâ??

A Randomized, Double Blind, Placebo controlled, clinical Study to evaluate the Efficacy and Safety of EASY CLIMB CAPSULES in Patients with Painful knee Osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/11/005205
Enrollment
50
Registered
2014-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M15-M19- Osteoarthritis

Interventions

Intervention1: EASY CLIMB Capsules 150 gm: EASY CLIMB Capsule is to be taken 2 capsules per day. One capsule in the morning & one in the night before food for 120 days Control Intervention1: Placebo 1

Sponsors

Natsyn Catalysts
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Men and women with age of 40 â?? 65 with a diagnosis of arthritis. • Obtaining written Inform consent along with audio, video visual. • Patients with mild to moderate arthritis • Participants who are able to visit the medical institutions throughout the study period

Exclusion criteria

Exclusion criteria: • Patients with Uncontrolled hypertension or diabetes. • Patients with Hepatic or renal impairment • Patients with Current or expected use of anticoagulant • Candidates for imminent joint replacement • Diagnosis of gastric or duodenal ulceration and/or history of significant gastro-duodenal bleeding, within the last 6 months • Participation within 30 days prior to screening in another investigational study • Conditions in the opinion of the investigator make the patient unsuitable to participate in the study. • Any contraindication to blood sampling. • HIV Positive serology • Pregnant (or) Lactating

Design outcomes

Primary

MeasureTime frame
â?¢ Patients Assessment of Osteoarthritis Pain by VAS [Osteoarthritis- Pain Visual analog scale (VAS)] â?¢ Change from Baseline in the WOMAC OA (Western Ontario and McMaster Universities Osteoarthritis) Index-pain subscale score â?¢ WOMAC Osteoarthritis Composite Index & QOL â?¢ Changes in the arthritis impact measurement scale (AIMS 2) â?¢ Change from Baseline in the CGI (Clinical Global Impression) scale score â?¢ Changes in Comprehensive Metabolic Panel (CMP), &Synovial Fluid analysis. Timepoint: â?¢Screening to EOT (Day 120)—

Secondary

MeasureTime frame
Safety assessed by Adverse EventsTimepoint: Screening to EOT (Day 120)—

Countries

India

Contacts

Public ContactDr Harisha S

ICBio Clinical research Pvt Ltd

harish@icbiocro.com9900111997

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026